Numinus Wellness Inc.

Good afternoon and welcome to Numinous Wellness Inc's fiscal fourth quarter and annual 2022 results conference call. A question and answer session for analysts and institutional investors will follow the formal remarks. As a reminder, this call is being recorded. I would now like to turn the conference call over to your host, Jamie Cocosa, Vice President of Investor Relations.

Please proceed.

Thank you, Brent. Good afternoon, everyone, and thank you for joining us for our fiscal fourth quarter and annual 2022 results conference call. Discussing Numinous' performance today are Peyton Nyquist, founder and CEO, and John Fong, chief financial officer. Joining them for analyst questions at the end of our formal remarks are Reid Robinson, chief clinical officer, and Paul Fieldking, chief science officer. The following discussion may include forward-looking statements that are based on current expectations and are subject to a number of risks and uncertainties. The risks and uncertainties that could cause our actual financial and operating results to differ significantly from our forward-looking statements are detailed in our MD&A for the quarter and the year ended August 31, 2022, and in our other Canadian securities filings available on CDAR. Numinous does not undertake to update or revise any forward-looking statements to reflect new events or circumstances, except as required by law. Our fourth quarter results are made available earlier this afternoon. We encourage you to review our earnings release, MD&A, and financial statements, which are available on our website as well as on CDAR. As a reminder, all figures discussed on today's call are in Canadian dollars. I'll now turn the call over to Peyton Nyquist, Chief Executive Officer.